Recent developments in the field of xenotransplantation have shown significant progress, particularly with pig organs. Massachusetts General Hospital has performed its second transplant of a genetically edited pig kidney into a living recipient, marking a major milestone in this innovative medical approach. Following the successful procedure, a New Hampshire man has become the second person known to be living with a pig kidney. This transplant trial aims to address the shortage of human organs for patients suffering from kidney failure. The FDA has approved multiple trials for pig organ transplants, paving the way for new possibilities in organ transplantation and potentially saving countless lives. Surgeons have reported that the gene-edited pig kidneys are functioning well in recipients, offering hope for the future of organ transplants and the advancement of xenotransplantation as a viable medical solution.